Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$392.81 - $485.53 $541,292 - $669,060
-1,378 Reduced 20.35%
5,394 $2.53 Million
Q1 2024

May 10, 2024

SELL
$407.69 - $446.08 $1.69 Million - $1.85 Million
-4,148 Reduced 37.99%
6,772 $2.83 Million
Q4 2023

Feb 09, 2024

SELL
$343.0 - $410.68 $1.41 Million - $1.69 Million
-4,123 Reduced 27.41%
10,920 $4.44 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $45,992 - $49,294
136 Added 0.91%
15,043 $5.23 Million
Q2 2023

Aug 11, 2023

BUY
$314.42 - $351.91 $4.69 Million - $5.25 Million
14,907 New
14,907 $5.25 Million
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $556,546 - $634,891
1,965 Added 17.55%
13,163 $4.15 Million
Q4 2022

Feb 10, 2023

SELL
$285.76 - $321.48 $650,104 - $731,367
-2,275 Reduced 16.89%
11,198 $3.23 Million
Q3 2022

Nov 10, 2022

BUY
$273.83 - $305.53 $1.94 Million - $2.16 Million
7,073 Added 110.52%
13,473 $3.9 Million
Q2 2022

Aug 12, 2022

BUY
$234.96 - $292.55 $276,782 - $344,623
1,178 Added 22.56%
6,400 $1.8 Million
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $1.16 Million - $1.36 Million
5,222 New
5,222 $1.36 Million
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $462,907 - $518,030
-2,552 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$187.49 - $221.1 $212,801 - $250,948
1,135 Added 80.1%
2,552 $515,000
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $146,363 - $170,606
-707 Reduced 33.29%
1,417 $304,000
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $1.4 Million - $1.86 Million
-6,748 Reduced 76.06%
2,124 $502,000
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $883,015 - $1.05 Million
-3,454 Reduced 28.02%
8,872 $2.41 Million
Q2 2020

Aug 11, 2020

SELL
$225.48 - $295.8 $11,048 - $14,494
-49 Reduced 0.4%
12,326 $3.58 Million
Q1 2020

May 08, 2020

SELL
$199.77 - $247.81 $1.55 Million - $1.92 Million
-7,744 Reduced 38.49%
12,375 $2.94 Million
Q4 2019

Feb 07, 2020

BUY
$166.71 - $223.91 $2.66 Million - $3.57 Million
15,959 Added 383.63%
20,119 $4.41 Million
Q3 2019

Nov 08, 2019

SELL
$166.23 - $187.09 $3.61 Million - $4.07 Million
-21,739 Reduced 83.94%
4,160 $705,000
Q2 2019

Aug 09, 2019

BUY
$164.61 - $190.37 $4.26 Million - $4.93 Million
25,899 New
25,899 $4.75 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Ontario Teachers Pension Plan Board Portfolio

Follow Ontario Teachers Pension Plan Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ontario Teachers Pension Plan Board, based on Form 13F filings with the SEC.

News

Stay updated on Ontario Teachers Pension Plan Board with notifications on news.